DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2,460 Cr | ₹1,912 Cr | ₹1,947 Cr | ₹1,216 Cr | ₹954 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹2,460 Cr |
Mar2022 | ₹1,912 Cr |
Mar2021 | ₹1,947 Cr |
Mar2020 | ₹1,216 Cr |
Mar2019 | ₹954 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹2,460 Cr | 28.66 | |
Mar2022 | ₹1,912 Cr | -1.80 | |
Mar2021 | ₹1,947 Cr | 60.12 | |
Mar2020 | ₹1,216 Cr | 27.42 | |
Mar2019 | ₹954 Cr | - |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹104,312.3 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics | |
MANKIND PHARMA | ₹87,328.3 Cr | -6.6% | -6.6% | NA | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.9% |
5% |
19.2% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses